Utilization of Reactive Oxygen Species Targeted Therapy to Prolong the Efficacy of BRAF Inhibitors in Melanoma

This study suggests that the combination of A100 with a BRAF inhibitor could be a potential strategy to treat melanoma patients with BRAF mutations.

Source: Journal of Cancer - December 14, 2018 Category: Cancer & Oncology Authors: Long Yuan, Rosalin Mishra, Hima Patel, Safnas Abdulsalam, Kenneth D. Greis, Ana Luisa Kadekaro, Edward J. Merino, Joan T. Garrett Tags: Research Paper Source Type: research